TENAX THERAPEUTICS,

TENX
Delayed Quote. Delayed  - 06/24 04:00:01 pm
2.09USD +0.48%

TENAX THERAPEUTICS : Financial Statements and Exhibits (form 8-K/A)

03/30/2021 | 05:25pm

Item 9.01 Financial Statements and Exhibits.



(a) Financial Statements of Businesses Acquired.



The audited historical financial statements of PHPM for the year ended December
31, 2019
are filed as Exhibit 99.2 hereto and incorporated herein by reference.



The unaudited financial statements of PHPM for the nine months ended September
30, 2020
are filed as Exhibit 99.3 hereto and incorporated herein by reference.



(b) Pro Forma Financial Information.



The unaudited pro forma condensed combined balance sheet and statement of
operations of the Company as of and for the nine months ended September 30, 2020
and the unaudited pro forma condensed combined statement of operations of the
Company for the year ended December 31, 2019 are filed as Exhibit 99.4 hereto
and incorporated herein by reference.




(d)
Exhibits.

Exhibit No. Description
2.1 Agreement and Plan of Merger among PHPrecisionMed Inc., Tenax
Therapeutics, Inc.
, Life Newco II, Inc., and Dr. Stuart Rich dated
January 15, 2021*
4.1 Certificate of Designation of Series B Convertible Preferred Stock*
10.1 Employment Agreement with Dr. Stuart Rich dated January 15, 2021*
23.1 Consent of Independent Registered Public Accounting Firm
99.1 Press Release dated January 19, 2021*
99.2 Audited financial statements of PHPrecisionMed Inc. as of and for the
year ended December 31, 2019
99.3 Unaudited financial statements of PHPrecisionMed Inc. as of and for the
nine months ended September 30, 2020
99.4 Unaudited pro forma condensed combined financial information of the
Company as of and for the nine months ended September 30, 2020 and the
unaudited pro forma condensed combined statement of operations of the
Company for the year ended December 31, 2019



*Filed with the Original From 8-K, which was filed with the SEC on January 19,
2021
.

© Edgar Online, source Glimpses

© Acquiremedia 2021
Copier lien
All news about TENAX THERAPEUTICS, INC.
06/11
06/10
05/17
05/17
05/17